Breast Cancer Screening AI
Breast Cancer Screening
CommercialActive
Key Facts
About Vara
Vara is a Berlin-based AI/ML diagnostics company, founded in 2018, that has established a significant presence in the European breast cancer screening market. Its core technology is a CE IIb-certified AI platform validated in a large-scale, 460,000-participant prospective study published in Nature Medicine, and it is reportedly deployed across 40% of Germany's national screening program. The company offers two main product lines: 'Vara Plugin' for integration into existing systems and 'Vara Workflow' as a standalone web-based platform, both designed to improve radiologist efficiency and screening program quality through AI-assisted triage and automated reporting.
View full company profileTherapeutic Areas
Other Breast Cancer Screening Drugs
| Drug | Company | Phase |
|---|---|---|
| BREASTEST plus™ | Bcal Diagnostics | Commercial |
| Auria | Namida Lab | Commercial |
| Non-Contrast Breast MRI Screening Research | Ikonopedia | Research |
| Electrical Mammogram | NovaScan | Pre-clinical |
| Thermalytix | Niramai | Approved |
| KBCT for Primary Screening | Koning | Research / Aspirational |
| PRISM Randomized Controlled Trial | ScreenPoint Medical | Trial |